Read more about the article Beroni Group was invited to attend the 6th China BioMed Innovation and Investment Conference
The 6th China BioMed Innovation and Investment Conference

Beroni Group was invited to attend the 6th China BioMed Innovation and Investment Conference

  • Post author:
  • Post category:2021
  • Post comments:0 Comments

September 25-27, 2021, the sixth “China BioMed Innovation and Investment Conference(CBIIC)” was successfully held in Suzhou. With cutting-edge scientific research and advanced medical projects, the scientific research team of Beroni…

Continue ReadingBeroni Group was invited to attend the 6th China BioMed Innovation and Investment Conference

Beroni Group Announced the Latest Clinical Study of its SARS- CoV-2 Antigen Test Kit (Colloidal Gold Method)

  • Post author:
  • Post category:2021
  • Post comments:0 Comments

NEW YORK and SYDNEY, Australia, Aug. 31, 2021 -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni”), an Australia-based biopharmaceutical enterprise, announced the latest clinical study of its SARS-CoV-2 Antigen Test…

Continue ReadingBeroni Group Announced the Latest Clinical Study of its SARS- CoV-2 Antigen Test Kit (Colloidal Gold Method)

Beroni Group Signs MoU with tella, Inc to Collaborate in Immunotherapy for Cancer Treatment

  • Post author:
  • Post category:2021
  • Post comments:0 Comments

NEW YORK and SYDNEY,  Australia,  May  28,  2021 -  Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni”), an Australia-based diversified biopharmaceutical enterprise today announced that it has signed a Memorandum of…

Continue ReadingBeroni Group Signs MoU with tella, Inc to Collaborate in Immunotherapy for Cancer Treatment
Read more about the article Beroni Group’s SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) Has Received Export Permit
Beroni ’s SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method)

Beroni Group’s SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) Has Received Export Permit

  • Post author:
  • Post category:2021
  • Post comments:0 Comments

NEW YORK and SYDNEY, April 27, 2021, Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni”), an Australia-based diversified biopharmaceutical enterprise today announced that it has received the notification that its SARS-CoV-2 Antigen Test…

Continue ReadingBeroni Group’s SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) Has Received Export Permit